(Q34353523)

1 August 2017

1 reference

title

Adenoviruses as vaccine vectors (English)

1 reference

1 August 2017

1 reference

1 reference

Nia Tatsis

1

1 reference

PubMed ID

15451446

1 August 2017

Hildegund C J Ertl

series ordinal

2

1 reference

1 August 2017

1 October 2004

1 reference

1 August 2017

1 reference

1 August 2017

10

1 reference

1 August 2017

4

1 reference

1 August 2017

616-629

1 reference

Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Activation of adenoviral gene expression by protein IX is not required for efficient virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Requirement of the adenovirus IVa2 protein for virus assembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

The impact of adenovirus infection on the immunocompromised host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Fatal Disseminated Adenovirus Infections in Immunocompromised Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Genome type analysis of adenovirus types 3 and 7 isolated during successive outbreaks of lower respiratory tract infections in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Replication-defective vector based on a chimpanzee adenovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

The adenovirus E3 RID complex protects some cultured human T and B lymphocytes from Fas-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Chimpanzee adenovirus CV-68 adapted as a gene delivery vector interacts with the coxsackievirus and adenovirus receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

CD46 is a cellular receptor for group B adenoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Adenovirus serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Innate immune recognition: mechanisms and pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

The maturation of murine dendritic cells induced by human adenovirus is mediated by the fiber knob domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Adenovirus-induced maturation of dendritic cells through a PI3 kinase-mediated TNF-alpha induction pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Identification of adenovirus (ad) penton base neutralizing epitopes by use of sera from patients who had received conditionally replicative ad (addl1520) for treatment of liver tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Human adenovirus cloning vectors based on infectious bacterial plasmids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Origin of AIDS: contaminated polio vaccine theory refuted.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Construction of adenoviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

pAd5-Blue: direct ligation system for engineering recombinant adenovirus constructs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIV(mac251) challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Viral recombinant vaccines to the E6 and E7 antigens of HPV-16

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Induction of antibodies against structural proteins of hepatitis C virus in mice using recombinant adenovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

A simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Comparative analysis of the effects of packaging signal, transgene orientation, promoters, polyadenylation signals, and E3 region on growth properties of first-generation adenoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Stability of a recombinant adenoviral vector: optimization of conditions for storage, transport and delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Crystal structure of reovirus attachment protein sigma1 reveals evolutionary relationship to adenovirus fiber

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

A chimeric adenovirus vector encoding reovirus attachment protein sigma1 targets cells expressing junctional adhesion molecule 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Adenovirus fibre exchange alters cell tropism in vitro but not transgene-specific T CD8+ immune responses in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Enhanced gene transfer to mouse dendritic cells using adenoviral vectors coated with a novel adapter molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Detection of individual mouse splenic T cells producing IFN-gamma and IL-5 using the enzyme-linked immunospot (ELISPOT) assay.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Improved permeabilization procedure for flow cytometric detection of internal antigens. Analysis of interleukin-2 production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Phenotypic analysis of antigen-specific T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Immune effector mechanisms required for protection to rabies virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Oral Vaccination of Mice with Adenoviral Vectors Is Not Impaired by Preexisting Immunity to the Vaccine Carrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Single oral immunization with replication deficient recombinant adenovirus elicits long-lived transgene-specific cellular and humoral immune responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Induction of CD8+ T cells to an HIV-1 antigen upon oral immunization of mice with a simian E1-deleted adenoviral vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Rabies update for travel medicine advisors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Intracranial administration of adenovirus expressing HSV-TK in combination with ganciclovir produces a dose-dependent, self-limiting inflammatory response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

A cluster of cases of severe acute respiratory syndrome in Hong Kong.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Effects of a SARS-associated coronavirus vaccine in monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Epitopes involved in antibody-mediated protection from Ebola virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Antibodies, viruses and vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

7 January 2021

HIV vaccines 1983-2003.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Immunogenicity in Mamu-A*01 rhesus macaques of a CCR5-tropic human immunodeficiency virus type 1 envelope from the primary isolate (Bx08) after synthetic DNA prime and recombinant adenovirus 5 boost

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Activation of HIV-1-specific immune responses to an HIV-1 vaccine constructed from a replication-defective adenovirus vector using various combinations of immunization protocols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Replication-deficient recombinant adenoviruses expressing the human immunodeficiency virus Env antigen can induce both humoral and CTL immune responses in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Vaccine-induced immunity in baboons by using DNA and replication-incompetent adenovirus type 5 vectors expressing a human immunodeficiency virus type 1 gag gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Potent, persistent cellular immune responses elicited by sequential immunization of rhesus macaques with Ad5 host range mutant recombinants encoding SIV Rev and SIV Nef.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Overcoming immunity to a viral vaccine by DNA priming before vector boosting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Encapsulation of recombinant adenovirus into alginate microspheres circumvents vector-specific immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Hexon gene switch strategy for the generation of chimeric recombinant adenovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Efficient transduction of human monocyte-derived dendritic cells by chimpanzee-derived adenoviral vector.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Human adenovirus type 35: nucleotide sequence and vector development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Characterization of in vitro and in vivo gene transfer properties of adenovirus serotype 35 vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Induction of CD8+ T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

AIDS research. Merck reemerges with a bold AIDS vaccine effort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Mucosally Delivered E1-Deleted Adenoviral Vaccine Carriers Induce Transgene Product-Specific Antibody Responses in Neonatal Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Induction of mucosal immunity with a replication-defective adenoviral recombinant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Immunogenicity of an E1-deleted recombinant human adenovirus against rabies by different routes of administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Replication-Defective Adenoviral Vaccine Vector for the Induction of Immune Responses to Dengue Virus Type 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Development of a preventive vaccine for Ebola virus infection in primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Effect of vaccine delivery system on the induction of HPV16L1-specific humoral and cell-mediated immune responses in immunized rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Induction of CD8 T cells by vaccination with recombinant adenovirus expressing human papillomavirus type 16 E5 gene reduces tumor growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Efficient induction of T helper 1 CD4+ T-cell responses to hepatitis C virus core and E2 by a DNA prime-adenovirus boost.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Enhanced induction of hepatitis C virus-specific cytotoxic T lymphocytes and protective efficacy in mice by DNA vaccination followed by adenovirus boosting in combination with the interleukin-12 expression plasmid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Immunogenicity of the E1E2 proteins of hepatitis C virus expressed by recombinant adenoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Investigation of promoter function in human and animal cells infected with human recombinant adenovirus expressing rotavirus antigen VP7sc

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Protective immunity to rotavirus-induced diarrhoea is passively transferred to newborn mice from naive dams vaccinated with a single dose of a recombinant adenovirus expressing rotavirus VP7sc

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Oral or parenteral administration of replication-deficient adenoviruses expressing the measles virus haemagglutinin and fusion proteins: protective immune responses in rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

High-level expression of the measles virus nucleocapsid protein by using a replication-deficient adenovirus vector: induction of an MHC-1-restricted CTL response and protection in a murine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia--RSV recombinants or RSV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Mucosal immunization with a replication-deficient adenovirus vector expressing murine cytomegalovirus glycoprotein B induces mucosal and systemic immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Murine cytotoxic T cell response specific for human cytomegalovirus glycoprotein B (gB) induced by adenovirus and vaccinia virus recombinants expressing gB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Long-term immunity and protection against herpes simplex virus type 2 in the murine female genital tract after mucosal but not systemic immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Replication-defective recombinant adenovirus expressing the Epstein-Barr virus (EBV) envelope glycoprotein gp340/220 induces protective immunity against EBV-induced lymphomas in the cottontop tamarin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Induction of therapeutic T-cell responses to subdominant tumor-associated viral oncogene after immunization with replication-incompetent polyepitope adenovirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

Group C adenovirus DNA sequences in human lymphoid cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

7 January 2021

Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

7 January 2021

Development of a helper-independent human adenovirus vector and its use in the transfer of the herpes simplex virus thymidine kinase gene.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

7 January 2021

Construction of nondefective adenovirus type 5 bearing a 2.8-kilobase hepatitis B virus DNA near the right end of its genome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

7 January 2021

Generation of an adenovirus vector lacking E1, e2a, E3, and all of E4 except open reading frame 3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

7 January 2021

Generation of adenovirus vectors devoid of all viral genes by recombination between inverted repeats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

7 January 2021

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

7 January 2021

The use of an E1-deleted, replication-defective adenovirus recombinant expressing the rabies virus glycoprotein for early vaccination of mice against rabies virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

7 January 2021

Ovine adenovirus vectors overcome preexisting humoral immunity against human adenoviruses in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

7 January 2021

High-level eucaryotic in vivo expression of biologically active measles virus hemagglutinin by using an adenovirus type 5 helper-free vector system

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

7 January 2021

Immunogenicity of recombinant adenovirus-respiratory syncytial virus vaccines with adenovirus types 4, 5, and 7 vectors in dogs and a chimpanzee

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.013

7 January 2021

An efficient procedure to select and recover recombinant adenovirus vectors

1 reference

12 December 2020

Adenovirus vaccine strains genetically engineered to express HIV-1 or HBV antigens for use as live recombinant vaccines.

1 reference

12 December 2020

In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted.

1 reference

12 December 2020

Packaging capacity and stability of human adenovirus type 5 vectors.

1 reference

12 December 2020

Current use and future directions of adenovirus vaccine

1 reference

12 December 2020

Adenovirus virus-associated RNA and translation control

1 reference

12 December 2020

Development of a complementing cell line and a system for construction of adenovirus vectors with E1 and E2a deleted

1 reference

12 December 2020

Induction of genital immunity by DNA priming and intranasal booster immunization with a replication-defective adenoviral recombinant

1 reference

12 December 2020

Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit

1 reference

12 December 2020

Serologic classification of chimpanzee adenoviruses by hemagglutination and hemagglutination inhibition.

1 reference

12 December 2020

Control of adenovirus acute respiratory disease in U.S. Army trainees

1 reference

12 December 2020

A recombinant human adenovirus vaccine against rabies

1 reference

12 December 2020

10.1016/J.YMTHE.2004.07.013

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

15451446